Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Genome-wide association is a promising approach to identify common genetic variants that predispose to human disease. Because of the high cost of genotyping hundreds of thousands of markers on thousands of subjects, genome-wide association studies often follow a staged design in which a proportion (pi(samples)) of the available samples are genotyped on a large number of markers in stage 1, and a proportion (pi(samples)) of these markers are later followed up by genotyping them on the remaining samples in stage 2. The standard strategy for analyzing such two-stage data is to view stage 2 as a replication study and focus on findings that reach statistical significance when stage 2 data are considered alone. We demonstrate that the alternative strategy of jointly analyzing the data from both stages almost always results in increased power to detect genetic association, despite the need to use more stringent significance levels, even when effect sizes differ between the two stages. We recommend joint analysis for all two-stage genome-wide association studies, especially when a relatively large proportion of the samples are genotyped in stage 1 (pi(samples) >or= 0.30), and a relatively large proportion of markers are selected for follow-up in stage 2 (pi(markers) >or= 0.01).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Joint analyses provide more statistical power than the power that meta-analysis approaches (Skol, et al., 2006)”
From A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin (2016) · cites this paper as Skol, et al., 2006
In the citing paper
“Post-hoc power analysis was performed for odds ratios ranging from 1.05 to 1.30 and across allele frequencies using CaTS61 with the estimated effective sample size.”
From Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) · cites this paper as [61]
In the citing paper
“Using equations from Wray et al. 2010 and our current heritability estimates, the 88 variant PRS explained a minimum 16% of the genetic liability of PD assuming a global prevalence of 0.5% (2,31).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
In the citing paper
“In a high-risk population with a prevalence of 2%, the 1805 variant PRS explained a maximum 36% of PD heritable risk (2,31) (Table S4).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
In the citing paper
“maximum potential AUC estimated at 85% using the equations from Wray et al. 2010”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
Citations
Cites
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Self-citationThe Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355 · cited 1×
“Note that equation (1) allows evidence for association to be combined without assuming equal effect sizes and allele frequencies for the two stages.”
BackgroundComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
The International SNP Map Working Group, Laboratories:, C. S. H., Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., National Center for Biotechnology Information:, Marth, G., Sherry, S., et al. (2001) · Nature · doi:10.1038/35057149 · Cited by 2,977 · cited 1×
“, enabled by rapidly decreasing genotyping costs, massively multiplexed genotyping technologies and the large-scale SNP discovery and genotyping efforts of the SNP Consortiu”
BackgroundGenome-wide association studies for common diseases and complex traits
Hirschhorn, J. N., & Daly, M. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1521 · Cited by 2,863 · cited 1×
“The false positive rate corresponding to thresholds C1 and Cjoint is amarker 1⁄4 P(|z1| 4 C1 AND |zjoint| 4 Cjoint) 1⁄4 P(|z1| 4 C1) P(|zjoint| 4 Cjoint | |z1| 4 C1), which can be calculated numerically by evaluating a simple integral (see equation (2) below).”
BackgroundProspects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416
Association study designs for complex diseases
Cardon, L. R., & Bell, J. I. (2001) · Nature Reviews Genetics · doi:10.1038/35052543 · Cited by 1,395
Haplotype tagging for the identification of common disease genes
Johnson, G. C. L., Esposito, L., Barratt, B. J., Smith, A. N., Heward, J., Di Genova, G., Ueda, H., Cordell, H. J., Eaves, I. A., Dudbridge, F., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-233 · Cited by 1,174
Whole-Genome Patterns of Common DNA Variation in Three Human Populations
Hinds, D. A., Stuve, L. L., Nilsen, G. B., Halperin, E., Eskin, E., Ballinger, D. G., Frazer, K. A., & Cox, D. R. (2005) · Science · doi:10.1126/science.1105436 · Cited by 1,170
Genomic Control, a New Approach to Genetic-Based Association Studies
Devlin, B., Roeder, K., & Wasserman, L. (2001) · Theoretical Population Biology · doi:10.1006/tpbi.2001.1542 · Cited by 516
Cited by
Items 501–600 of 1,000
Grondin, Y., Bortoni, M. E., Sepúlveda, R., Ghelfi, E., Bartos, Á., Cotanche, D. A., Clifford, R. E., & Rogers, R. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130827 · Cited by 34
Ghesquières, H., Slager, S. L., Jardin, F., Véron, A. S., Asmann, Y. W., Maurer, M. J., Fest, T., Habermann, T. M., Béné, M. C., Novak, A. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2573 · Cited by 33
“Age, years Median 61 63 61 49 58 Range 18-93 20-92 18-88 18-60 18-93 60 270 (50) 185 (59) 200 (51) 0 (0) 655 (43) Male 307 (57) 156 (50) 229 (59) 174 (59) 865 (56) ECOG PS 2 101 (19) 34 (11) 79 (20) 45 (15) 259 (17) LDH ULN 217 (40) 164 (53) 189 (548) 213 (72) 783 (51) Stage III/IV 394 (73) 182 (58) 244 (62) 196 (67)…”
Multistage Sampling for Genetic Studies
Elston, R. C., Lin, D., & Gang, Z. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092357 · Cited by 33
“(50) studied a simple procedure to combine the test statistics in the two stages under various configurations of the design parameters.”
MethodGenetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease
Sookoian, S. C., Rohr, C., Salatino, A., Dopazo, H., Gianotti, T. F., Castaño, G. O., & Pirola, C. J. (2017) · Oncotarget · doi:10.18632/oncotarget.15286 · Cited by 33
“Using the CaTS power calculator for genetic association studies [33] and assuming a prevalence of NAFLD of 0.”
López‐Mejías, R., Carmona, F. D., Genre, F., Remuzgo‐Martínez, S., González‐Juanatey, C., Corrales, A., Vicente, E. F., Pulito‐Cueto, V., Miranda-Filloy, J. A., Huaranga, M. A. R., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40734 · Cited by 35
“Estimations for statistical power were obtained with CaTS Power Calculator for Genetic Studies software, which implements the methods described by Skol et al (21) (Supplementary Tables 1–4, on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40734/abstract).”
MethodInfluentialLin, M. H., Caberto, C., Wan, P. C., Li, Y., Lum‐Jones, A., Tiirikainen, M., Pooler, L., Nakamura, B. N., Sheng, X., Porcel, J., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa083 · Cited by 34
“For dichotomous trait, we computed power using the GAS power calculator (47) (http://csg.”
MethodBhatraju, P. K., Cohen, M., Nagao, R. J., Morrell, E. D., Harju-Baker, S., Chai, X.-Y., Nance, R. M., Dmyterko, V., Delaney, J. A., Christie, J. D., et al. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01935-1 · Cited by 32
Popanda, O., Seibold, P., Nikolov, I., Oakes, C. C., Burwinkel, B., Hausmann, S., Flesch‐Janys, D., Plass, C., Chang-Claude, J. C., & Schmezer, P. (2012) · International Journal of Cancer · doi:10.1002/ijc.27665 · Cited by 33
“The joint analysis approach was shown to have enhanced power compared with standard replication-based analysis and also takes heterogeneity between stages into account.(15) The findings of Set 1 were not confirmed.”
MethodInfluentialA functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis
Tan, W., Wu, H. L., Zhao, J., Derber, L. A., Lee, D. M., Shadick, N. A., Conn, D. L., Smith, E. A., Gersuk, V. H., Nepom, G. T., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27589 · Cited by 32
To Replicate or Not to Replicate: The Case of Pharmacogenetic Studies
Aslibekyan, S. W., Claas, S. A., & Arnett, D. K. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.000010 · Cited by 37
Schmit, S. L., Schumacher, F. R., Edlund, C. K., Conti, D. V., Raskin, L., Lejbkowicz, F., Pinchev, M., Rennert, H. S., Jenkins, M. A., Hopper, J. L., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu148 · Cited by 32
“analysis[42], we also conducted a fixed-effects meta-analysis of SNPs with p<5x10 -8 from the”
MethodGenome-Wide Association Study in Humans
Smith, J. G., & Newton‐Cheh, C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-247-6_14 · Cited by 37
Nakayama, R. T., Sato, Y., Masutani, M., Ogino, H., Nakatani, F., Chuman, H., Beppu, Y., Morioka, H., Yabe, H., Hirose, H., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00692.x · Cited by 32
Raina, P., Sikka, R., Gupta, H., Matharoo, K., Bali, S. K., Singh, V., & Bhanwer, A. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10041-2 · Cited by 31
Katki, H. A., Berndt, S. I., Machiela, M. J., Stewart, D. R., García‐Closas, M., Kim, J., Shi, J., Yu, K. F., & Rothman, N. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-01973-x · Cited by 31
“Parenthetically, the Genet ic Assoc iatio n Study (GAS) Power Calcu lator [13, 33] substitutes the variance under the alternative for the variance under the null (i.”
BackgroundDesign Considerations for Genetic Linkage and Association Studies
Nsengimana, J., & Bishop, D. T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7274-6_13 · Cited by 33
Power and Sample Size Calculations for SNP Association Studies With Censored Time‐to‐Event Outcomes
Owzar, K., Li, Z., Cox, N. J., & Jung, S. (2012) · Genetic Epidemiology · doi:10.1002/gepi.21645 · Cited by 33
“Power and sample size calculation methods and software for designing case-control studies have been published extensively [e.g., De La Vega et al., 2005; Edwards et al., 2005; Hao et al., 2004; Klein, 2007; Lange et al., 2004; Menashe et al., 2008; Michael and Otta, 2002; Skol et al., 2006; Spencer et al., 2009].”
MethodValidation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain
Swaminathan, B., Matesanz, F., Cavanillas, M. L., Alloza, I., Otaegui, D., Olascoaga, J., Cénit, M. C., Heras, V. D. L., Barcina, M. G., Arroyo, R., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.020 · Cited by 32
“Power was calculated using the CATS power calculator (Skol et al., 2006), set at one-stage design (http:// www.”
A Genome-Wide Association Study of Total Serum and Mite-Specific IgEs in Asthma Patients
Kim, J.-H., Cheong, H. S., Park, J., Jang, A., Uh, S. T., Kim, Y.-H., Kim, M.-K., Choi, I. S., Cho, S., Choi, B. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071958 · Cited by 31
“Statistical power analysis of linear regression for total IgE was obtained from a two-tailed t-test; case-control analysis for specific IgE was obtained from the CaTS power calculator [21], using heritability estimates for total IgE (0.”
MethodTowards the genetic basis of cerebral venous thrombosis—the BEAST Consortium: a study protocol
Cotlarciuc, I., Marjot, T., Khan, M. S., Hiltunen, S., Haapaniemi, E., Metso, T. M., Putaala, J., Zuurbier, S. M., Brouwer, M. C., Passamonti, S. M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012351 · Cited by 31
“Power calculations were performed using the genetic power calculator CaTS.”
MethodRaina, J. K., Sharma, M., Panjaliya, R. K., Dogra, V., Bakaya, A., & Kumar, P. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01618-7 · Cited by 30
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6
Swaminathan, B., Cuapio, A., Alloza, I., Matesanz, F., Alcina, A., García‐Barcina, M., Fedetz, M., Fernández, Ó., Lucas, M., Órpez, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062376 · Cited by 35
“edu/csg/abecasis/ CaTS) [36].”
García-Bermúdez, M., López‐Mejías, R., González‐Juanatey, C., Corrales, A., Castañeda, S., Ortiz, A. M., Miranda-Filloy, J. A., Gómez‐Vaquero, C., Fernández‐Gutiérrez, B., Balsa, A., et al. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1836 · Cited by 30
“Statistical power for the study was calculated using CaTS - Power Calculator for Two Stage Association Studies (http:// sph.umich.edu/csg/abecasis/CaTS/) (Skol et al., 2006).”
MethodJacobsson, J. A., Almén, M. S., Benedict, C., Hedberg, L., Michaëlsson, K., Brooks, S. J., Kullberg, J., Axelsson, T., Johansson, L. O. M., Ahlström, H. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020158 · Cited by 33
“edu/csg/abecasis/CaTS)[31] and Power and Sample Size Calculation (biostat.”
BackgroundGenome Wide Assessment of Young Onset Parkinson’s Disease from Finland
Hernandez, D. G., Nalls, M. A., Ylikotila, P., Keller, M. F., Hardy, J., Majamaa, K., & Singleton, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041859 · Cited by 35
“Although the current study was not designed to detect common low risk variants, and our effective power to do so was zero [17], it is notable that the size and direction of effect for each of these variants is consistent with the previous report (Table 1) [6].”
MethodResultGenomics models in radiotherapy: From mechanistic to machine learning
Kang, J., Coates, J. T. T., Strawderman, R. L., Rosenstein, B. S., & Kerns, S. L. (2020) · Medical Physics · doi:10.1002/mp.13751 · Cited by 31
Rizzi, T. S., Vásquez, A. A., Rommelse, N. N. J., Kuntsi, J., Anney, R., Asherson, P. J., Buitelaar, J. K., Banaschewski, T., Ebstein, R. P., Ruano, D., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31149 · Cited by 32
“We thus conducted a metaanalysis, in which the primary sample was included to increase statistical power [Skol et al., 2006].”
MethodInfluentialPinelli, M., Giacchetti, M., Acquaviva, F., Cocozza, S., Donnarumma, G., Lapice, E., Riccardi, G., Romano, G., Vaccaro, O., & Monticelli, A. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-85 · Cited by 30
“We estimated the power for our genetic association study using CATS software [27].”
MethodZhao, J. H. (2004) · doi:10.32614/cran.package.gap · Cited by 30
ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
Siokas, V., Aloizou, A.-M., Tsouris, Z., Liampas, I., Liakos, P., Calina, D., Docea, A. O., Tsatsakis, A., Bogdanos, D. P., Hadjigeorgiou, G. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030381 · Cited by 29
“The calculation of the power of the sample was carried out with the CaTS Power Calculator [41].”
MethodComparison of two‐phase analyses for case–control genetic association studies
Zheng, G., Meyer, M., Li, W., & Yang, Y. (2008) · Statistics in Medicine · doi:10.1002/sim.3336 · Cited by 29
“Our two-phase analysis is different from the two-stage design of Skol et al. [ 7 ], who considered a two-stage cost-effective genotyping design with a joint analysis.”
MethodResultLüthi, F., Dériaz, O., Vuistiner, P., Burrus, C., & Hilfiker, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094268 · Cited by 34
A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener’s granulomatosis
Wieczorek, S., Holle, J. U., Müller, S., Fricke, H., Gross, W. L., & Epplen, J. T. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0580-y · Cited by 29
“02 power calculator [33], applying a multiplicative model for each marker (significance threshold 0.”
Genetics of Diabetic Nephropathy: Are There Clues to the Understanding of Common Kidney Diseases?
Conway, B. R., & Maxwell, A. P. (2009) · Nephron Clinical Practice · doi:10.1159/000224787 · Cited by 32
Murphy, A., Weiss, S. T., & Lange, C. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000197 · Cited by 30
“While this is a cost-effective approach, it is not as powerful as genotyping all subjects [33].”
Wei, J. C., Wong, H. S.-C., Hsu, Y.-W., Wen, Y., Wang, W., Wong, R., Lu, H.-F., van Gaalen, F. A., & Chang, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137189 · Cited by 29
“We used CaTS to calculate the power of association between HLA-B27/B60 to AS susceptibility [13].”
MethodGene-environment interactions in chronic obstructive pulmonary disease
Molfino, N. A., & Coyle, A. J. (2008) · International Journal of COPD · doi:10.2147/copd.s2528 · Cited by 29
Polymorphisms of the Tumor Suppressor GeneLSAMPare Associated with Left Main Coronary Artery Disease
Wang, L., Hauser, E. R., Shah, S. H., Seo, D., Sivashanmugam, P., Exum, S. T., Gregory, S. G., Granger, C. B., Haines, J. L., Jones, C. J. H., et al. (2008) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2008.00433.x · Cited by 35
“These corrections range from the most conservative Bonferroni correction, to False Discovery Rate, to weighted correction of combined data, to no correction at all (Benjamini & Hochberg 1995; Skol et al. 2006).”
Discovering Findings That Replicate From a Primary Study of High Dimension to a Follow-Up Study
Bogomolov, M., & Heller, R. (2013) · Journal of the American Statistical Association · doi:10.1080/01621459.2013.829002 · Cited by 32
Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits
Deming, Y., Xia, J., Cai, Y., Lord, J., Del-Aguila, J. L., Fernandez, M. V., Carrell, D., Black, K., Budde, J., Ma, S., et al. (2016) · Scientific Reports · doi:10.1038/srep18092 · Cited by 28
“…and 2) it has been shown that combining data from both stages of a two-stage GWAS to perform a single analysis almost always has increased power to identify genetic association than analyzing the groups separately even though a lower statistical threshold is required to determine significance 11 .”
Adaptive Two-Stage Analysis of Genetic Association in Case-Control Designs
Zheng, G., Song, K. S., & Elston, R. C. (2007) · Human Heredity · doi:10.1159/000099830 · Cited by 28
Couturier, N., Gourraud, P., Cournu‐Rebeix, I., Gout, C., Bucciarelli, F., Edan, G., Babron, M., Clerget‐Darpoux, F., Clanet, M., Fontaine, B., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.259 · Cited by 30
Association of Toll-like receptor polymorphisms with HIV status in North Americans
Willie, B., Hall, N. B., Stein, C. M., Jurevic, R. J., Weinberg, A., Mehlotra, R. K., & Zimmerman, P. A. (2014) · Genes and Immunity · doi:10.1038/gene.2014.54 · Cited by 28
Influence of TNF-α-308 G/A gene polymorphism on temporomandibular disorder
Furquim, B. D., Fiamengui, L. M. S. P., Repeke, C. E. P., Cavalla, F., Garlet, G. P., & Conti, P. C. R. (2016) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2015.10.026 · Cited by 30
“The study's power calculation was performed with CATS software (Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor) as previously described using multiplicative, additive, and dominant models.(25)”
MethodA post-GWAS analysis of predicted regulatory variants and tuberculosis susceptibility
Uren, C., Henn, B. M., Franke, A., Wittig, M., van Helden, P. D., Hoal, E. G., & Möller, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174738 · Cited by 31
“The CaTS power calculator was used to perform power calculations [29].”
MethodX-chromosome association study reveals genetic susceptibility loci of nasopharyngeal carcinoma
Zuo, X.-Y., Feng, Q.-S., Sun, J., Wei, P.-P., Chin, Y., Guo, Y., Xia, Y., Li, B., Xia, X., Jia, W., et al. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0227-9 · Cited by 31
“in this study, following the methods described previously [34].”
Wason, J. M. S., & Dudbridge, F. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.007 · Cited by 30
“Of course, greater improvements in power are possible from a joint analysis of the two stages when the assumption in the first stage is explicitly controlled for.(4,29) This was done in the WTCCC study, when cases from clinically distinct diseases were pooled with the controls so that the total sample size increased.”
BackgroundPalmer, N. D., Langefeld, C. D., Ziegler, J. T., Hsu, F., Haffner, S. M., Fingerlin, T. E., Norris, J. M., Chen, Y. I., Rich, S. S., Haritunians, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1586-2 · Cited by 32
“This result might thus have been excluded from further consideration, but it is noteworthy that methodological studies by Skol et al. [ 40 ] have suggested that an approach using joint analysis of data is more efficient than replication-based analysis for two-stage GWAS.”
MethodPower Calculations in Genetic Studies
Evans, D. M., & Purcell, S. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top069559 · Cited by 33
“…to one-stage approaches where all markers in all individuals are genotyped, two-stage designs can lead to appreciable savings in genotyping costs while still maintaining power (Satagopan et al. 2002, 2004; Satagopan and Elston 2003; Maraganore et al. 2005; Thomas et al. 2005; Skol et al. 2006).”
Ko, J. M. Y., Dai, W., Wong, E. H. W., Kwong, D. L. �., Ng, W. T., Lee, A., Ngan, R. K., Yau, C. C., Tung, S. Y., & Lung, M. L. (2014) · International Journal of Cancer · doi:10.1002/ijc.28802 · Cited by 27
“5 using the additive model with significance level a 5 10(25), assuming a disease allele frequency 30–40%.(24) What’s new?”
MethodCommon polymorphisms in FMO1 are associated with nicotine dependence
Hinrichs, A. L., Murphy, S. E., Wang, J. C. C., Saccone, S. F., Saccone, N. L., Steinbach, J. H., Goate, A., Stevens, V. L., & Bierut, L. J. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328346886f · Cited by 30
González‐Serna, D., Ortiz‐Fernández, L., Vargas, S., García, A., Raya, E., Fernández‐Gutiérrez, B., López‐Longo, F. J., Balsa, A., González‐Álvaro, I., Narváez, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26573-4 · Cited by 27
Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer’s Disease Risk?
Stamati, P., Siokas, V., Aloizou, A., Karampinis, E., Arseniou, S., Rakitskii, V. N., Tsatsakis, A. M., Spandidos, D. A., Gozes, I., Mitsias, P. D., et al. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01363-3 · Cited by 30
Lack of replication in polymorphisms reported to be associated with atrial fibrillation
Sinner, M. F., Lubitz, S. A., Pfeufer, A., Makino, S., Beckmann, B.-M., Lunetta, K. L., Steinbeck, G., Perz, S., Rahman, R. M. A., Sonni, A., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.11.003 · Cited by 27
Current thinking on genetics of chronic obstructive pulmonary disease
Molfino, N. A. (2007) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328013e97d · Cited by 27
Association Study of TRPC4 as a Candidate Gene for Generalized Epilepsy with Photosensitivity
von Spiczak, S., Muhle, H., Helbig, I., de Kovel, C. G. F., Hampe, J., Gaus, V., Koeleman, B. P. C., Lindhout, D., Schreiber, S., Sander, T., et al. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8122-x · Cited by 27
“Power calculation ( Skol et al. 2006 ) for the whole group revealed a likelihood of 80% to detect a sequence variant with a”
BackgroundGenome-wide association study identifies PERLD1 as asthma candidate gene
Anantharaman, R., Andiappan, A. K., Parate, P. N., Suri, B. K., Wang, D. Y., & Chew, F. T. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-170 · Cited by 27
“4 [31].”
Genetic Survey of Adult-Onset Idiopathic Intracranial Hypertension
Kuehn, M. H., Mishra, R., Deonovic, B., Miller, K. N., McCormack, S. E., Liu, G. T., Kupersmith, M. J., Wall, M., & the NORDIC IIHTT Study Group (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000648 · Cited by 27
Design Considerations for Genetic Linkage and Association Studies
Nsengimana, J., & Bishop, D. T. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-555-8_13 · Cited by 31
Allelic Association: Linkage Disequilibrium Structure and Gene Mapping
Collins, A. R. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9110-3 · Cited by 39
“[31] indicate, however, that joint analysis of data from both stages is always more powerful.”
BackgroundThe role of family-based designs in genome-wide association studiesPreprint
Laird, N. M., & Lange, C. (n.d.) · Cited by 27
MacInnes, S. J., Vescovo, E. D., Kiss‐Toth, E., Ollier, W., Kay, P., Gordon, A. C., Greenfield, E. M., & Wilkinson, J. M. (2014) · Journal of Orthopaedic Research® · doi:10.1002/jor.22755 · Cited by 26
Zheng, H.-F., Duncan, E. L., Yerges‐Armstrong, L. M., Eriksson, J., Bergström, U., Leo, P. J., Leslie, W. D., Goltzman, D., Blangero, J., Hanley, D. A., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101287 · Cited by 26
Kim, D. S., Crosslin, D. R., Auer, P. L., Suzuki, S. M., Marsillach, J., Burt, A., GORDON, A. S., Meschia, J. F., Nalls, M. A., Worrall, B. B., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p049247 · Cited by 29
“analysis; thus, we analyzed all 4,204 subjects together(15).”
MethodLessons learned in the analysis of high-dimensional data in vaccinomics
Oberg, A. L., McKinney, B. A., Schaid, D. J., Pankratz, V. S., Kennedy, R. B., & Poland, G. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.088 · Cited by 30
“Splitting a sample into two low-powered samples has lower power than a single sample analysis[52].”
BackgroundReclassification of genetic-based risk predictions as GWAS data accumulate
Krier, J. B., Barfield, R., Green, R. C., & Kraft, P. L. (2016) · Genome Medicine · doi:10.1186/s13073-016-0272-5 · Cited by 26
“Here β and q are the log OR and minor allele frequencies for a SNP, Mj is the number of SNPs observed in bin i; pj is the power to observe a SNP with effect size corresponding to bin j, given the largest sample size studied up to the time point [38]:”
BackgroundGonzález‐Serna, D., Ochoa, E., López‐Isac, E., Julià, A., Degenhardt, F. C., Ortego‐Centeno, N., Radstake, T. R. D. J., Franke, A., Marsal, S., Mayes, M. D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58741-w · Cited by 29
SCN1A variations and response to multiple antiepileptic drugs
Yip, T. S. C., O’Doherty, C., Tan, N. C., Dibbens, L. M., & Suppiah, V. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.43 · Cited by 28
Kim, J., Choi, G. H., Ko, K. H., Kim, J. O., Oh, S. H., Park, Y. S., Kim, O. J., & Kim, N. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162519 · Cited by 28
Oussalah, A., Levy, J., Filhine-Trésarrieu, P., Namour, F., & Guéant, J. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.156349 · Cited by 31
Tangtanatakul, P., Thumarat, C., Satproedprai, N., Kunhapan, P., Chaiyasung, T., Klinchanhom, S., Wang, Y., Wei, W., Wongshinsri, J., Chiewchengchol, D., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02276-y · Cited by 27
Evaluating cost efficiency of SNP chips in genome‐wide association studies
Li, C., Li, M., Long, J., Cai, Q., & Zheng, W. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20312 · Cited by 26
“Because a GWA scan is expensive, cost efficiency is an important factor to consider in study design [Skol et al., 2006].”
BackgroundPeacock, M., Koller, D. L., Lai, D., Hui, S. L., Foroud, T., & Econs, M. J. (2009) · Bone · doi:10.1016/j.bone.2009.05.002 · Cited by 29
“These results emphasize the need to aim for maximum power as has been recommended for association studies [13].”
MethodOn Combining Data From Genome-Wide Association Studies to Discover Disease-Associated SNPs
Pfeiffer, R. M., Gail, M. H., & Pee, D. (2009) · Statistical Science · doi:10.1214/09-sts286 · Cited by 30
“As is evident from the literature on detection probability (Gail et al., 2008a, 2008b) and power calculations (Skol et al., 2006, 2007), large sample sizes are needed to have a good chance to discover diseaseassociated SNPs with odds ratios commonly found in GWA studies.”
BackgroundAssociation of Kallikrein Gene Polymorphisms With Intracranial Aneurysms
Weinsheimer, S., Goddard, K. A. B., Parrado, A., Lu, Q. L., Sinha, M., Разумовна, Л. Е., Ronkainen, A., Niemela, M. R., Хуснутдинова, Э. К., Khusainova, R. I., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.486225 · Cited by 30
Advances in statistical human genetics over the last 25 years
Elston, R. C., & Spence, M. A. (2006) · Statistics in Medicine · doi:10.1002/sim.2650 · Cited by 29
“It is possible to control the amount of multiple testing involved by using multistage designs [209, 210], in which case an appropriate analysis of the results of all stages combined together, rather than considering each stage separately as a replication, increases power [211].”
BackgroundKelley-Hedgepeth, A., Peter, I., Kip, K. E., Montefusco, M. C., Kogan, S., Cox, D. H., Ordovás, J. M., Levy, D. A., Reís, S. E., Mendelsohn, M. E., et al. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.23 · Cited by 26
Müller, H., Pahl, R., & Schäfer, H. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20245 · Cited by 26
“The final statistical test is based on joint analysis of the promising markers in the full sample of n cases and controls [Skol et al., 2006].”
Hebbar, P., Abu‐Farha, M., Alkayal, F., Nizam, R., Elkum, N. B., Melhem, M., John, S. E., Channanath, A. M., Abubaker, J. A., Bennakhi, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57072-9 · Cited by 26
Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility
Manso, H., Krug, T., Sobral, J., Albergaria, I., Gaspar, G., Ferro, J. M., Oliveira, S. A., & Vicente, A. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.011 · Cited by 25
Robust ranks of true associations in genome-wide case-control association studies
Zheng, G., Joo, J., Lin, J., Stylianou, M. P., Waclawiw, M. A., & Geller, N. L. (2007) · BMC Proceedings · doi:10.1186/1753-6561-1-s1-s165 · Cited by 25
“[10]) in which only a portion of samples will be genotyped in the first stage to select markers to be genotyped using the remaining samples.”
BackgroundOhi, K., Hashimoto, R., Yasuda, Y., Yoshida, T., Takahashi, H., Iike, N., Iwase, M., Kamino, K., Ishii, R., Kazui, H., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.002 · Cited by 25
“edu/csg/abecasis/CaTS/; (Skol et al., 2006)]. Power estimates were based on allele frequencies in patients ranging from 0.17 (SNP4) to 0.29 (SNP3), odds ratios ranging from 1.29 (SNP3) to 1.49 (SNP4) for each associated SNP, as indicated by Zhao et al. (2007), and an alpha level of 0.”
InfluentialCommon germ-line polymorphism of C1QA and breast cancer survival
Azzato, E. M., Lee, A. J. X., Teschendorff, A. E., Ponder, B. A. J., Pharoah, P. D. P., Caldas, C., & Maia, A.-T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605625 · Cited by 25
Inborn variation in metabolism
Mootha, V. K., & Hirschhorn, J. N. (2010) · Nature Genetics · doi:10.1038/ng0210-97 · Cited by 25
Association of polymorphisms in the Chr18q11.2 locus with tuberculosis in Chinese population
Wang, X., Tang, N. L. S., Leung, C. C., Kam, K. M., Yew, W. W., Tam, C. M., & Chan, C. Y. (2013) · Human Genetics · doi:10.1007/s00439-013-1282-7 · Cited by 25
Martin, J.-E., Carmona, F. D., Broen, J. C. A., Simeón‐Aznar, C. P., Vonk, M. C., Carreira, P. E., Ríos-Fernández, R., Espinosa, G., Vicente‐Rabaneda, E. F., Tolosa-Vilella, C., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.72 · Cited by 26
On the covariance of two correlated log‐odds ratios
Bagos, P. G. (2012) · Statistics in Medicine · doi:10.1002/sim.4474 · Cited by 25
“Usually in GWAS the investigators are interested in replicating their initial significant findings (stage 1) and a combined analysis of the results of both stages (stage 1 and stage 2) has been shown to be more powerful than relying on the replication stage alone [29].”
MethodA Genetic Deconstruction of Neurocognitive Traits in Schizophrenia and Bipolar Disorder
Fernandes, C. P. D., Christoforou, A., Giddaluru, S., Ersland, K. M., Djurovic, S., Mattheisen, M., Lundervold, A. J., Reinvang, I., Nöthen, M. M., Rietschel, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081052 · Cited by 25
“This is potentially a more efficient and powerful approach for analyzing the data [49] than testing independent samples.”
BackgroundGolbus, J. R., Stitziel, N. O., Zhao, W., Xue, C., Farrall, M., McPherson, R., Erdmann, J., Deloukas, P., Watkins, H. C., Schunkert, H., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001374 · Cited by 27
“The power calculation formula was modified from Skol to incorporate unequal numbers of cases and controls.(34) Table 1.”
Ohnami, S., Sato, Y., Yoshimura, K., Ohnami, S., Sakamoto, H., Aoki, K., Ueno, H., Ikeda, M., Morizane, C., Shimada, K., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.016 · Cited by 25
A Functional Polymorphism in the TIM-1 Gene Is Associated with Asthma in a Chinese Han Population
Liu, Q., Shang, L., Li, J., Wang, P., Li, H., Wei, C., & Gong, Y. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000103992 · Cited by 25
“Power calculation was performed using the computer program CaTS power calculator to evaluate the type II error [22].”
MethodLevenstien, M. A., Ott, J., & Gordon, D. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020127 · Cited by 27
“These follow-up or replication studies involve recruiting an independent sample of cases and controls for which only SNPs in the promising regions will be genotyped [62].”
BackgroundSonehara, K., Kimura, Y. J., Nakano, Y., Ozawa, T., Takahashi, M., Ken, S., Fujii, T., Matsushita, Y., Tomiyama, A., Kishikawa, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32005-9 · Cited by 24
Tully, L. J., Murphy, A. M., Smith, R. K. W., Hulin-Curtis, S. L., Verheyen, K. L. P., & Price, J. S. (2013) · Equine Veterinary Journal · doi:10.1111/evj.12134 · Cited by 24
Teruel, M., McKinney, C., Balsa, A., Pascual‐Salcedo, D., Rodríguez‐Rodríguez, L., Ortiz, A. M., Gómez‐Vaquero, C., González-Gay, M. Á., Smith, M., Witte, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068295 · Cited by 24
“The estimation of the power of the study to detect an effect of a polymorphism in disease susceptibility was performed using the the CaTS Power Calculator software [10] (see URL: http://www.”
MethodITGA4 polymorphisms and susceptibility to multiple sclerosis
O’Doherty, C., Roos, I. M., Antigüedad, A. R., Aransay, A. M., Hillert, J. A., & Vandenbroeck, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.006 · Cited by 24
Lin, C., Chen, M., Wu, V., Li, W. ‐., Sy, H. ‐., Wu, S.-L., Chang, C.-C., Chiu, P. ‐., Liou, H., Lin, C., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12337 · Cited by 24
“Power calculations were completed using the CATs Genetic Power Calculator with settings of a multiplicative genetic model.”
MethodHennings, J. M., Kohli, M. A., Czamara, D., Giese, M., Eckert, A., Wolf, C., Heck, A., Domschke, K., Arolt, V., Baune, B. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064947 · Cited by 26
“The CaTS Power Calculator for Genetic Studies [32] was used for power calculation using a two-stage design.”
MethodPostula, M. A., Janicki, P. K., Rosiak, M., Kapłon‐Cieślicka, A., Trzepla, E., Filipiak, K. J., KOSIOR, D. A., Członkowski, A., & Opolski, G. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0823-6 · Cited by 24
“The calculations of the approximate power statistics and sample size for pooling studies were performed using CaTS—power calculator for two stage association studies [11].”
IL18 Gene Variants Influence the Susceptibility to Chagas Disease
Rodríguez, D., Carmona, F. D., Echeverría, L. E., González, C. I., & Martin, J. J. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004583 · Cited by 24
Metadata
- Authors
- Skol, A. D., Scott, L. J., Abecasis, G. R., & Boehnke, M.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Boehnke, Michael
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 2
- Pages
- 209-213
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2140126911
- Cited by
- 1,286
- References
- 21
- Citations by year
- 2026: 7 · 2025: 32 · 2024: 35 · 2023: 32 · 2022: 36 · 2021: 45 · 2020: 47 · 2019: 56 · 2018: 55 · 2017: 76 · 2016: 65 · 2015: 52 · 2014: 70 · 2013: 69 · 2012: 95
- FWCI
- 61.77
- Type
- journal article
- Language
- en
- Update notices
- erratum (2006-03-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Forensic and Genetic Research
- Keywords
- joint analysis, statistical power, sample allocation, marker selection, effect size heterogeneity, significance level
- MeSH terms
- Alleles, DNA Replication, Gene Frequency, Genetic Markers, Genetics, Medical, Genotype, Humans, Genome, Human, Case-Control Studies, Genetic Heterogeneity, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.